Next Century Growth Investors’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
Other funds holding ADMA
RCMNY
CP
Next Century Growth Investors's ADMA Position: Q2 2026 in Review
Next Century Growth Investors sold out of ADMA Biologics (ADMA) in Q2 2026, closing a stake of 774,436 shares — an estimated $6.98M sold.
Next Century Growth Investors first reported a position in ADMA in Q3 2025 and held it in 3 quarters. The position peaked at $20.1M in Q4 2025. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.
- Next Century Growth Investors reported no remaining ADMA Biologics position as of Q2 2026 after selling out during the quarter.
- Next Century Growth Investors sold 774,436 ADMA Biologics shares in Q2 2026, an estimated $6.98M.
- Next Century Growth Investors first reported a position in ADMA Biologics in Q3 2025 and held it in 3 quarters.
- Next Century Growth Investors's ADMA Biologics position peaked at $20.1M in Q4 2025.
- 323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.
Based on Next Century Growth Investors's 13F filing for Q2 2026, filed 14 Aug 2026.